Using in vitro assays for therapeutic enzyme characterization

BioProcess International

Volumn 7, Issue 11, 2009, Pages 40-44

  Lundblad, Roger ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Activity; Hyaluronidase; Proteases; Thrombin; Validation

Indexed keywords

HYALURONIDASE; THROMBIN;

BIOTECHNOLOGY; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME CONFORMATION; ENZYME MECHANISM; ENZYME SUBSTRATE COMPLEX; IN VITRO STUDY; REVIEW;

EID: 77953420483     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (34)

1. Racker E (National Academy of Sciences-National Research Council). International Unit of Enzyme Activity. Science 128, 1958: 19-20.
2. Dybkaer R. Unit "Katal" for Catalytic Activity (IUPAC Technical Support). Pure Appl. Chem. 73, 2001: 927-931.
3. Dybkaer R. The Tortuous Road to the Adsorption of Katal for the Expression of Catalytic Activity By the General Conference on Weights and Measures. Clin. Chem. 48, 2002: 586-590.
4. Contemporary Enzyme Kinetics and Mechanism. Purich D, Ed. Academic Press: New York, NY, 1981.
5. ICH Q8 (R2): Pharmaceutical Development. Fed. Reg. 71(98) 2006; www.ich.org/LOB/media/MEDIA4986.pdf.
6. Lundblad RL, et al. A Review of the Therapeutic Uses of Thrombin. Thromb. Haemost. 91, 2004: 851-860.
7. Spotnitz WD, Prabhu R. Fibrin Sealant Tissue Adhesive: Review and Update. Long Term Eff. Med. Implants 15, 2005: 245-270.
8. Lewis SD, Shields PP, Shafer JA. Characterization of the Kinetic Pathway for Liberation of Fibrinopeptides During Assembly of Fibrin. J. Biol. Chem. 260, 1985: 10192-10199.
9. Gaffney PJ, Edgell TA. The International and "NIH" Units for Thrombin: How Do They Compare? Thromb. Haemost. 74, 1995: 900-903.
10. Jenny NS, Lundblad RL, Mann KG. Chapter 10: Thrombin. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Fifth Edition. Colman RW, et al., Eds. Goldhaber, Lippincott, William, and Wilkins: Philadelphia, PA, 2007: 193-213.
11. Lundblad RL, et al. Bovine α- and β-Thrombin: Reduced Fibrinogen-Clotting Activity Is Not a Consequence of Reduced Affinity for Fibrinogen. J. Biol. Chem. 259, 1984: 6991-6695.
12. Menzel EJ, Farr C. Hyaluronidase and Its Substrate Hyaluronan: Biochemistry, Biological Activities and Therapeutic Uses. Cancer Lett. 131, 1998: 3-11.
13. Bergquist S, Packalen T. The Bacteriological Origin of a Spreading Factor Present in the Nasal Secretion. Acta Pathol. Microbiol. Scand. 25, 1948: 255-258.
14. Girish KS, Kemparaju K. The Magic Glue Hyaluronan and Its Eraser Hyaluronidase: A Biological Overview. Life Sci. 80, 2007: 1921-2007.
15. Frost GI. Recombinant Human Hyaluronidase (rHuPH20): An Enabling Platform for Subcutaneous Drug and Fluid Administration. Expert Opin. Drug Deliv. 4, 2007: 427-440.
16. Gandhi NS, Mancera RL. The Structure of Glycosaminoglycans and Their Interactions with Proteins. Chem. Biol. Drug. Des. 72, 2008: 455-482.
17. Vercruysse KP, Lauwers AR, Demeester JM. Absolute and Empirical Determination of the Enzymatic Activity and Kinetic Investigation of the Action of Hyaluronidase on Hyaluronan Using Viscosimetry. Biochem. J. 305, 1995: 153-160.
18. Menzel EJ, Farr C. Hyaluronidase and Its Substrate Hyaluronan: Biochemistry, Biological Activities and Therapeutic Uses. Cancer Lett. 131, 1998: 3-11.
19. Frost GI, Stern R. A Micro-Titer Assay for Hyaluronidase Activity Not Requiring Specialized Reagents. Anal. Biochem. 251, 1997: 263-269.
20. Bailey LC, Levine NA. Optimization of the USP Assay for Hyaluronidase. J. Pharmaceut. Biomed. Anal. 11, 1993: 285-292.
21. Maksiemenko AV, Schechilina YV, Tischenko EG. Resistance of Detran-Modified Hyaluronidase to Inhibition By Heparin. Biochem. J. 66, 2001: 456-463.
22. Fujiwara S, et al. Effects of Pressure on the Activity and Spectroscopic Properties of Carboxyl Proteinases: Apparent Correlation of Pepstatin- Insensitivity and Pressure Response. Eur. J. Biochem. 268, 2001: 645-655.
23. Larner J, Takeda Y, Hizukuri S. The Influence of Chain Size and Molecular Weight on the Kinetic Constants for the Span Glucose to Polysaccharide for Rabbit Muscle Glycogen Synthase. Molec. Cell. Biochem. 12, 1976: 131-136.
24. Neet KE. Chapter 11: Cooperativity in Enzyme Function: Equilibrium and Kinetic Aspects. Contempory Enzyme Kinetics and Mechanism. Purich DL, Ed. Academic Press: New York, NY, 1983.
25. Tanaka K, et al. High Quality Human Immunoglobulin G Purified from Cohn Fractions By Liquid Chromatography. Braz. J. Med. Biol. Res. 33, 2000: 27-30.
26. Snape TJ, et al. The Assay of Prekallikrein Activator in Human Blood Products. Dev. Biol. Stand. 44, 1979: 115-120.
27. Kerry PJ, et al. Standardization of Prekallikrein Activator (PKA): The 1st British Reference Preparation of PKA. Brit. J. Haematol. 52, 1985: 275-281.
28. Tankersley DL, Fournel MA, Schroeder DD. Kinetics of Activation of Prekallikrein Activator. Biochem. J. 19, 1980: 3121-3127.
29. Lundblad JL. In Vitro Assay for Prekallikrein Activator (PKA). Develop. Biol. Standard. 44, 1979: 107-114.
30. Gan Q, Allen SJ, Taylor, G. Kinetic Dynamics in Heterogeneous Hydrolysis of Cellulose: An Overview, an Experimental Study and Mathematical Modeling. Process Biochem. 38, 2003: 1003-1018.
31. Chen RL, James RF. Characterization of an Important Enzymatic Component in Collagenase That Is Essential for the Effective Digestion of the Human and Porcine Pancreas. Cell Transplant. 10, 201: 709-716.
32. Dedrick SC, Ramirez-Rico J. Potency and Stability of Frozen Urokinase Solutions in Syringes. Am. J. Health Syst. Pharm. 61, 2004: 1586-1589.
33. Lichtinghagen R. Determination of Pulmozyme (Dornase Alpha) Stability Using a Kinetic Colorimetrc DNase I Activity Assay. Eur. J. Pharm. Biopharm. 63, 2006: 365-368.
34. Luthra S, et al. Investigation of Drying Stress on Proteins During Lyophilization: Differentiation Between Primary and Secondary-Drying Stresses on Lactate Dehydrogenase Using a Humidity Controlled Mini Freeze-Dryer. J. Pharm. Sci. 96, 2007: 61-70. c